Sourced from:Manufacturer Authorized Distributor
Quick Summary
Bdpoma 1mg Capsule
Last updated on 31 Mar 2026 | 09:31 AM (IST)
₹1650
MRP: ₹1940.63
(You Save ₹290.63)
21 CAPSULE(s) IN A BOTTLE
Sourced from:Manufacturer Authorized Distributor
Bdpoma 1mg Capsule
Salt Composition
POMALIDOMIDEMarketer
BDR PHARMACEUTICALS INTERNATIONALS PVT LTD
15% OFF
₹1650
MRP: ₹1,940.63
Inclusive of all taxes
15% Off
Salt Composition
POMALIDOMIDEMarketer
BDR PHARMACEUTICALS INTERNATIONALS PVT LTD
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Our Recommendation
Pomalid 1mg Capsule
NATCO PHARMA LTD
POMALIDOMIDE
₹ 2,557
MRP:₹ 3,955.95
Substitutes
Pomabuzz 1mg Capsule
JASGUR LIFE SCI...
₹ 54.19/capsule
31% cheaper
Pomamac 1mg Capsule
ADMAC LIFE SCIE...
₹ 99.14/capsule
27% costlier
Pomide 1mg Capsule
HETERO HEALTHCA...
₹ 121.10/capsule
55% costlier
Pomalid 1mg Capsule
NATCO PHARMA LT...
₹ 121.76/capsule
55% costlier
Introduction to Bdpoma 1mg Capsule
Bdpoma 1mg Capsule is a chemotherapy medicine containing the active constituent Pomalidomide. It belongs to the group of medications known as Immuno modulatory agents. It is used to treat multiple myeloma in adults. Multiple myeloma is a type of cancer mainly affecting certain white blood cells called the plasma cell. These cells grow uncontrolled and accumulate in the bone marrow, damaging the bones and kidneys.
The common side effects that are likely to associate with Bdpoma 1mg Capsule are shortness of breath, tiredness, weakness, nausea, vomiting, diarrhea, constipation, back and bone pain, dizziness, tremor, upper respiratory tract infection, sleeping trouble, loss of appetite, lack of energy, muscle spasms, muscle weakness, numbness, tingling or burning sensation, the low potassium level in the blood and anemia. Inform your doctor if these side effects disturb or persist in you.
Inform your medical professional if you are allergic to Bdpoma 1mg Capsule and its ingredients. Inform your doctor if you have high cholesterol levels, heart disorders, breathing problems, blood clot disorders, hepatitis B infection, neuropathy (Pain in hands or feet caused by nerve damage), or if you smoke before taking this chemotherapy medicine. It is not recommended for adolescents and children under 18 years of age.
Uses of Bdpoma 1mg Capsule
- Treatment of Multiple myeloma.
Therapeutic Effects of Bdpoma 1mg Capsule
Bdpoma 1mg Capsule works by stimulating the immune system to attack the cancer cells, stopping the formation of blood vessels supplying the cancer cells, and preventing the growth of cancer cells (myeloma cells).
Interaction of Bdpoma 1mg Capsule with other drugs
Inform your doctor about any prescribed medications, over-the-counter medications, nutritional or vitamin supplements and herbal products that you are taking or have taken before the treatment. Certain medications may interact with Bdpoma 1mg Capsule and can cause potential side effects.
More Information about Bdpoma 1mg Capsule
- Keep Bdpoma 1mg Capsule out of sight and reach of children.
- Store at room temperature between 20°C to 25°C.
How to consume Bdpoma 1mg Capsule
Always take Bdpoma 1mg Capsule exactly as prescribed by your doctor. Take this medicine with or without food. Swallow the Capsule as a whole with water. Do not crush or chew the Capsule.
Safety Advice for Bdpoma 1mg Capsule
Breast Feeding
It is not recommended to use during breastfeeding as it is unknown if Bdpoma 1mg Capsule passes into breast milk and harms the baby.
Alcohol
It is not known whether it is safe to consume alcohol with Bdpoma 1mg Capsule. Please consult your doctor.
Liver
Bdpoma 1mg Capsule is used with caution in severe liver disease patients. A dose adjustment is required. Your physician will perform blood tests to monitor your liver function during treatment with this medication.
Lungs
It is unknown whether Bdpoma 1mg Capsule can be given to patients with lung disorders. Consult your doctor if you have any lung problems before starting the treatment.
Driving
Do not drive or operate heavy machines while taking Bdpoma 1mg Capsule, as it can cause tiredness, dizziness, and confusion.
Pregnancy
Bdpoma 1mg Capsule is unsafe to use during pregnancy as it may cause harmful effects on the unborn baby. Inform your doctor if you are pregnant or planning to get pregnant before taking this medicine.
Side Effects of Bdpoma 1mg Capsule
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Serious:
- Low white blood cells
- Bleeding or bruising
- Severe or bloody diarrhea
- Blood clots (chest or leg pain, swelling)
- Severe liver problems (yellowing of skin or eyes, dark-brow color urine, abdominal Pain)
- Severe allergic reactions (swelling of face, lips, tongue, or throat, difficulty breathing)
Common:
- Shortness of breath
- Tiredness, weakness
- Nausea, vomiting
- Dizziness, tremor
- Low potassium level in the blood (hypokalaemia)
- Back pain, bone pain
- Diarrhea, constipation
- Upper respiratory tract infection
- High blood sugar levels
- Loss of appetite, lack of energy
- Trouble sleeping
- Muscle spasms, muscle weakness
- Numbness, tingling, or burning sensation in the skin, Pain in hands or feet
- Anemia
Word of Advice
It is recommended to take effective birth control for at least 4 weeks before beginning treatment, during treatment, and at least 4 weeks after stopping Bdpoma 1mg Capsule treatment. Women who are pregnant or suspect they may be pregnant should not use this medication. Handle this medication with disposable gloves since it may come into contact with the skin. Do not share Bdpoma 1mg Capsule with others even if they have the same symptoms as you have, since it may cause birth defects and other serious problems. It is advised to refrain from donating blood or sperm both during treatment and for seven days after treatment with this drug.
FAQs about Bdpoma 1mg Capsule
Q1.
What class of medication is Bdpoma 1mg Capsule?
Bdpoma 1mg Capsule belongs to the class of medications called Immuno modulatory agents.
Q2.
What is the best time to take Bdpoma 1mg Capsule?
It is best to take Bdpoma 1mg Capsule once daily, with or without food. Take the capsule at the same time every day for better results.
Q3.
Can children use Bdpoma 1mg Capsule?
No, Bdpoma 1mg Capsule is not recommended for usage in children under 18.
Q4.
Can I donate blood during Bdpoma 1mg Capsule treatment?
Blood donations are restricted while taking Bdpoma 1mg Capsule and for one month after stopping the medicine because the blood might be given to pregnant women whose fetuses should not be exposed to this medication.
Q5.
In which conditions should I avoid taking Bdpoma 1mg Capsule?
Bdpoma 1mg Capsule should not be used in patients with blood clots, heart attack, heart failure, breathing difficulty, high blood pressure and cholesterol levels, neuropathy, and hepatitis B virus infection.
Q6.
Can I share Bdpoma 1mg Capsule with other people?
No, sharing Bdpoma 1mg Capsule medication with others is not recommended, even if they have the same symptoms as you. Hence, it may cause birth defects and other problems.
Q7.
What should I do if I miss my Bdpoma 1mg Capsule dose?
Take your missed Bdpoma 1mg Capsule dose as soon as you remember if it has been less than 12 hours since your usual time. Skip the dose you missed if it has been more than 12 hours. Do not take two doses at the same time.
Q8.
I am suffering from a Hepatitis B virus infection. Can I take Bdpoma 1mg Capsule?
Bdpoma 1mg Capsule should not be used in patients with hepatitis B virus infection. Bdpoma 1mg Capsule treatment may reactivate the hepatitis B virus in people who have the virus, resulting in a recurrence of the infection.
Fact Box of Bdpoma 1mg Capsule
Molecule name: Pomalidomide | Therapeutic class: Immunomodulatory agents |
Pharmacological class: Antineoplastics | Indications: Multiple myeloma |
References
1.Bristol-Myers Squibb Pharma EEIG, Electronic medicines compendium (EMC), [ Revised on Feb 2022] [ Accessed on 28 Nov 2022], https://www.medicines.org.uk/emc/files/pil.1262.pdf
2.Celgene corporation, US Food and Drug Administration, [ Revised on Dec 2017] [ Accessed on 28 Nov 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204026s019lbl.pdf
3.Rafael Rios-Tamayo et al; Pomalidomide in the treatment of multiple myeloma: design, development and place in therapy; Drug Design, Development and Therapy; Published on 28/08/2017; Accessed on 28/09/2022; https://www.ncbi.nlm.nih.gov/pubmed/28860711
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Guruvigneshwari M.
M. Pharm
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 31 Mar 2026 | 09:31 AM (IST)
Want to know more?
Read Our Editorial Policy
